nucleoside analog/cell differentiation inducer (Invenio)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenucleoside analog/cell differentiation inducer (Invenio)
Drug Alias Namenucleoside analog (Invenio)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell differentiation stimulants
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInvenio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvenio Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A